The DOI matches its Crossref record.
MicroRNA‐132 and microRNA‐223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease
Abstract
Background and Aim: Although many progresses have been achieved for inflammatory bowel disease (IBD), it is still remained as idiopathic disease to be completely controlled. MicroRNAs (miRNAs) have been identified as key players in many human diseases through degradation or translational inhibition of target genes. Because role of miRNAs in IBD is not completely understood yet, we need to identify miRNAs as novel targets for treatment of IBD. Methods: Microarray analysis for miRNAs was performed using dextran sulfate sodium‐induced colitis samples and selected differentially regulated miRNAs. Candidate genes were validated using in vitro system and IBD patient samples. Molecular mechanism for regulation of inflammatory signaling was identified using gene modulation system of miRNAs. Results: We selected 14 upregulated and 15 downregulated miRNAs through microarray analysis. Among candidate miRNAs, significant upregulation of miR‐132 and miR‐223 was confirmed in inflamed mouse tissues as well as human IBD patient tissues. Through bioinformatics analysis, we identified FOXO3a as direct target of miRNAs and confirmed regulatory mechanism using luciferase assay. Expression of miRNAs clearly suppressed the level of IκBα through downregulation of FOXO3a, leading to enhanced NF‐κB signaling to promote the production of pro‐inflammatory cytokines. The downregulation of FOXO3a concurrent with upregulation of cytokines was significantly reversed by sequestration of miRNAs with miRNA sponges. Conclusions: Our findings provided the evidences that miR‐132 and 223 are critical mediators in positive circuit for pathogenesis of IBD by negatively regulating FOXO3a to enhance the expression of inflammatory cytokines and can be a good therapeutic target for IBD treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the case of IBD, LPS stimulation induces the inhibition of FOXO3a by miR-223, which subsequently down-regulates IκB-α and activates the NF-κB signaling pathway to release pro-inflammatory cytokines, thus promoting IBD progression (Figure 9) 115.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 34
- 10.1038/nature06005 · DOI · Paper page
- 10.1136/gut.48.4.526 · DOI · Paper page
- 10.3748/wjg.14.338 · DOI
- 10.1007/s00535-007-2111-3 · DOI
- 10.1016/j.cell.2009.01.002 · DOI · Paper page
- 10.1038/labinvest.2009.66 · DOI
- 10.1002/hep.23100 · DOI · Paper page
- 10.1086/605443 · DOI · Paper page
- 10.1136/gut.2009.181834 · DOI · Paper page
- 10.1053/j.gastro.2008.07.068 · DOI · Paper page
- 10.1097/MEG.0b013e32835c34ea · DOI
- 10.1371/journal.pone.0013160 · DOI · Paper page
- 10.1111/j.1440-1746.2009.06216.x · DOI · Paper page
- 10.1038/modpathol.2013.152 · DOI
- 10.1371/journal.pone.0016841 · DOI
- 10.1371/journal.pone.0042971 · DOI · Paper page
- 10.1016/j.neuron.2007.05.017 · DOI · Paper page
- 10.1073/pnas.0605298103 · DOI · Paper page
- 10.1038/cddis.2013.22 · DOI
- 10.1371/journal.pone.0095370 · DOI
- 10.1097/MIB.0b013e318281f47d · DOI
- 10.1146/annurev.immunol.21.120601.141126 · DOI · Paper page
- 10.1016/S0016-5085(00)70216-2 · DOI · Paper page
- 10.1016/S0016-5085(98)70196-9 · DOI · Paper page
- 10.1074/jbc.M110.101055 · DOI · Paper page
- 10.1093/hmg/ddt164 · DOI · Paper page
- 10.1111/acel.12245 · DOI
- 10.1111/joim.12099 · DOI · Paper page
- 10.1016/j.immuni.2009.09.019 · DOI · Paper page
- 10.1038/ncb2054 · DOI · Paper page
- 10.4049/jimmunol.1201516 · DOI · Paper page
- 10.4049/jimmunol.1103060 · DOI
- 10.1074/jbc.M513918200 · DOI
- 10.4291/wjgp.v5.i2.63 · DOI
Cited by
Critical role of FOXO3a in carcinogenesis
Liu, Y., Ao, X., Ding, W., Ponnusamy, M., Wu, W., Hao, X., Yu, W., Wang, Y., Li, P., & Wang, J. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0856-3 · Cited by 507
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
Metadata
- Authors
- Kim, H., Kwon, H. Y., Ha Thi, H. T., Lee, H. J., Kim, G. I., Hahm, K., & Hong, S.
- Affiliations
- Department of Molecular Medicine, Lee Gil Ya Cancer and Diabetes Institute Gachon University Incheon Korea
- Department of Pathology CHA Bundang Medical Center Seongnam Korea
- CHA Cancer Prevention Research Center CHA University Seongnam Korea
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2016-10
- Volume
- 31
- Issue
- 10
- Pages
- 1727-1735
- ISSN
- 0815-9319
- 1440-1746
- Cited by
- 52
- References
- 0
- Language
- en
- Funders
- Ministry of Education (2012R1A1A2004620)
- Gachon University Gil Medical Center (FRD2014‐09)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNA‐132 and microRNA‐223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease. https://app.cochat.ai/papers/10.1111/jgh.13321
- The paper
- Kim, H., Kwon, H. Y., Ha Thi, H. T., Lee, H. J., Kim, G. I., Hahm, K., & Hong, S. (2016). MicroRNA‐132 and microRNA‐223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.13321
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.